Table 1.
Baseline characteristics of the cohort according to the presence or absence of aortic calcification
| Characteristic | Calcification (n = 38) | No calcification (n = 74) | P-value |
|---|---|---|---|
| Male (%) | 68.4 | 58.1 | 0.29 |
| Age (year) | 56 ± 8 | 45 ± 12 | <0.001 |
| Black race (%) | 52.6 | 29.7 | 0.02 |
| Dialysis vintage (year) | 3.3 ± 3.0 | 1.8 ± 2.2 | 0.003 |
| Preemptive transplant (%) | 13.2 | 29.7 | 0.05 |
| Living donor transplant (%) | 28.9 | 44.6 | 0.11 |
| BMI (kg/m2) | 26.7 ± 5.0 | 27.5 ± 5.2 | 0.48 |
| Diabetes (%) | 44.7 | 29.7 | 0.11 |
| Hypertension (%) | 92.1 | 93.2 | 0.83 |
| Active smoker (%) | 10.8 | 9.5 | 0.82 |
| ACE inhibitor or ARB use (%) | 13.2 | 21.6 | 0.32 |
| CVD (%) | 7.9 | 9.5 | 0.78 |
| CRP (mg/L) | 5.2 ± 7.4 | 3.5 ± 5.1 | 0.09 |
| Total cholesterol (mg/dL) | 170 ± 37 | 174 ± 47 | 0.66 |
| Triglycerides (mg/dL) | 188 ±150 | 180 ± 170 | 0.82 |
| LDL (mg/dL) | 91 ± 30 | 95 ± 38 | 0.61 |
| HDL (mg/dL) | 43 ± 13 | 46 ± 19 | 0.40 |
| sICAM (ng/mL) | 261 ± 78 | 293 ± 80 | 0.06 |
| Systolic blood pressure (mmHg) | 138 ± 27 | 134 ± 20 | 0.38 |
| Diastolic blood pressure (mmHg) | 73 ± 12 | 74 ± 12 | 0.64 |
| ApoA1 (mg/dL) | 120 ± 26 | 125 ± 27 | 0.34 |
| Lipoprotein A (mg/dL) | 36 ± 32 | 47 ± 48 | 0.15 |
| Calcium (mg/dL) | 9.3 ± 1.4 | 9.2 ± 0.86 | 0.68 |
| Phosphorus (mg/dL) | 5.0 ± 1.3 | 5.1 ± 1.3 | 0.68 |
| Albumin (g/dL) | 3.59 ± 0.5 | 3.91 ± 0.44 | 0.001 |
| CAC mean | 709.9 (842.3) | 192.0 (506.1) | <0.001 |
| CAC median | 436.4 | 3.9 | <0.001 |
ACE, angiotensin-converting enzyme; ApoA1, apolipoprotein A; ARB, angiotensin receptor blocker; BMI, body mass index; CAC, coronary artery calcium score; CRP, C-reactive protein; CVD, cardiovascular disease; LDL, low-density lipoprotein; HDL, high-density lipoprotein; sICAM, soluble intracellular adhesion molecule.